Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Julie Tracey"'
Autor:
Dhruv Parekh, Simon Ball, Catherine Snelson, Farrukh Rauf, Jeremy Willson, Shyam Madathil, Kay Por Yip, Simon Gompertz, Brendan Cooper, Syed SA Huq, Natasha Salmon, Joyce Tengende, Julie Tracey, Kay Filby, Davinder P S Dosanjh
Publikováno v:
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
Introduction Many respiratory clinical trials fail to reach their recruitment target and this problem exacerbates existing funding issues. Integration of the clinical trial recruitment process into a clinical care pathway (CCP) may represent an effec
Externí odkaz:
https://doaj.org/article/9971d5820a1d439da98b70005f51dc9c
Autor:
Dhruv Parekh, Natasha Salmon, Shyam Madathil, Farrukh Rauf, Julie Tracey, Kay Filby, Syed Huq, Brendan G Cooper, Davinder Dosanjh, Jeremy Willson, Simon Gompertz, Catherine Snelson, Kay Por Yip
Publikováno v:
Noninvasive ventilatory support.
Autor:
Natasha Salmon, Farrukh Rauf, Kay Por Yip, Julie Tracey, Kay Filby, Syed Huq, Simon Gompertz, Joyce Tengende, Davinder Dosanjh, Shyam Madathil, Catherine Snelson, Brendan G Cooper, Simon Ball, Dhruv Parekh, Jeremy Willson
Publikováno v:
BMJ Open Respiratory Research
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
BMJ Open Respiratory Research, Vol 8, Iss 1 (2021)
IntroductionMany respiratory clinical trials fail to reach their recruitment target and this problem exacerbates existing funding issues. Integration of the clinical trial recruitment process into a clinical care pathway (CCP) may represent an effect
Autor:
James O. Kahn, Donald I. Abrams, Donald W. Northfelt, Julie Tracey, Howard Grossberg, Padraic Neville, John Mills, Paul A. Volberding, Suzanne M. Crowe, Lawrence D. Kaplan
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 9(6)
Thirty patients with human immunodeficiency virus (HIV)-associated non-Hodgkin's lymphoma (NHL) receiving chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) were randomized to receive either subcutaneous recombinant h